Oramed Pharmaceuticals
ORMP
ORMP
15 hedge funds and large institutions have $1.91M invested in Oramed Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
44% less capital invested
Capital invested by funds: $3.37M → $1.91M (-$1.47M)
Holders
15
Holding in Top 10
–
Calls
$507K
Puts
$123K
Top Buyers
| 1 | +$1.2M | |
| 2 | +$31.4K | |
| 3 | +$15K | |
| 4 |
Morgan Stanley
New York
|
+$4.62K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$4.17K |
Top Sellers
| 1 | -$2.61M | |
| 2 | -$75K | |
| 3 | -$27.8K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$11.5K |
| 5 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
-$11K |